Internet guide to St. Petersburg, the cultural capital of Russia Internet Explorer: add to favorites 
St. Petersburg guide / Home page
 News | Events | Playbill | City | Tourism | Accommodation | Business
 Culture | Dine & Wine | Nightlife | Family | Health & Sports | Excursions
Services | Shopping | Classifieds | Forums | Map | Weather | Articles

Personal live guide to PetersburgOnline Map of St. PetersburgVisa support for your trips
 in St.Petersburg: March 29, 2024; 6:24am (GMT+4). Search:
 Business news All business news in St. Petersburg 
Warning: current() expects parameter 1 to be array, null given in /home/webs/city.air.spb.ru/system/advert.robo on line 24
News at PetersburgCity.com
City news
Business news
Culture news

Hot topics
Visa Support
“Stars of the White
Nights” Festival

“Day of the City”
program


Popular search words this week

Business news
Novartis to Invest $500 Million, Build Plant in Russia
12.21.2010 00:16

Novartis AG

Novartis AG, Europe’s third-largest drug company by sales, signed a memorandum of understanding with the city of St. Petersburg as part of a five-year, $500 million investment in Russia.

Novartis will build a new plant in the country for the production of branded generics as well as pharmaceuticals, the Basel, Switzerland-based company said in a statement today. Construction will start in 2011 and the plant will produce about 1.5 billion units per year, the company said.

“Novartis is making a strategic investment in Russia for long-term growth,” Novartis Chief Executive Officer Joseph Jimenez said in the statement. The agreement “enables us to expand our commercial presence in a key emerging market.”

Drugmakers such as Novartis are seeking growth in Russia as part of a wider push in emerging markets, where sales are rising faster than in developed countries. The Russian government has pledged to improve health care in the country and develop a local pharmaceutical industry, Novartis said.

The Swiss drugmaker said it plans to expand its research and development and public-health collaborations with the Russian government. As part of the project, Novartis may license some of its own compounds to Russian companies or buy rights to promising drug candidates from Russian scientists and universities, the company said.

Novartis also pledged to double its investments in drug development in clinical trials in Russia and expects to enroll about 4,000 people in studies by 2013, the company said

News source: Bloomberg L.P.
Print this news


Business news archive for 21 December' 2010.
Business news archive for December' 2010.
Business news archive for 2010 year.
Culture news archive
December' 2010
SuMoTuWeThFrSa
   1234
567891011
12131415161718
19202122232425
262728293031 
       
Archive for 2010 year


 News | Events | Playbill | City | Tourism | Accommodation | Business
 Culture | Dine & Wine | Nightlife | Family | Health & Sports | Excursions
Services | Shopping | Classifieds | Forums | Map | Weather | Articles

Site Map | Search | Help/feedback | About | Advertise with us

Contacts: info@petersburgcity.com

(c) 2001-2016 "Information Resources" Agency